22157.jpg
Kidney Transplant Market Predicted to Reach $7.34 Billion by 2028, Driven by Innovations and Rising Demand for Transplants
28 janv. 2024 19h49 HE | Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Kidney Transplant Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global interest in the kidney transplant...
Sigyn Therapeutics Logo.jpg
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
14 sept. 2022 09h00 HE | Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage company focused on the creation of therapeutic solutions that address...
HealthMap_150x.90_1200.jpg
Rapid National Growth Drives Expansion of Healthmap Solutions Executive Leadership Team with Eric Reimer Appointed Chief Executive Officer
01 oct. 2020 12h00 HE | Healthmap Solutions
TAMPA, Fla., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Healthmap Solutions (Healthmap), a growing specialty Population Health Management (PHM) company with an industry-leading Kidney Health Management (KHM)...
HealthMap_150x.90_1200.jpg
Regence and Healthmap Solutions partner to provide Kidney Health Management program to members
11 juin 2020 09h00 HE | Healthmap Solutions
PORTLAND, Ore., June 11, 2020 (GLOBE NEWSWIRE) -- Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney...
American Kidney Fund
American Kidney Fund’s Kidney Kitchen™ Wins 2019 Gold MarCom Award
05 déc. 2019 09h30 HE | American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF)’s online Kidney Kitchen™ has won a Gold 2019 MarCom Award in the Digital Media – Website – Nonprofit category. ...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
31 oct. 2019 17h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel,...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
23 sept. 2019 16h20 HE | Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
07 août 2019 08h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2019 Financial Results
08 mai 2019 08h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15 avr. 2019 16h30 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...